Meningitis and Encephalitis

Meningitis and encephalitis represent two of the most urgent neurological emergencies you will encounter. While both involve inflammation within the central nervous system (CNS), their primary sites of infection differ critically, dictating distinct clinical presentations and management priorities. Timely diagnosis and the immediate initiation of empiric therapy are not just best practices—they are lifesaving interventions that directly prevent death and devastating neurological sequelae.

Defining the Conditions and Pathophysiology

Understanding the anatomical target of the infection is the first step. Meningitis is an inflammation of the meninges, the protective membranes (the pia, arachnoid, and dura mater) that surround the brain and spinal cord. The infectious process and subsequent inflammatory response occur primarily in the subarachnoid space, where cerebrospinal fluid (CSF) circulates. In contrast, encephalitis denotes inflammation of the brain parenchyma itself—the functional tissue containing neurons and glial cells. This direct neuronal invasion or immune-mediated attack leads to altered brain function.

The blood-brain barrier (BBB) is a highly selective border that normally protects the CNS from pathogens and toxins. However, microorganisms can bypass this defense through hematogenous spread (traveling in the bloodstream), direct extension from a nearby infection (like sinusitis), or retrograde travel along cranial nerves. Once they gain entry, the resulting inflammation causes the cardinal symptoms: in meningitis, it's irritation of the meninges and increased intracranial pressure; in encephalitis, it's direct neuronal dysfunction.

Clinical Presentation and the Imperative for Rapid Assessment

The classic triad of bacterial meningitis is fever, headache, and nuchal rigidity (neck stiffness). However, this triad is not universally present. Patients are often acutely ill, with symptoms developing over hours to a couple of days. Key signs include photophobia (light sensitivity), altered mental status ranging from confusion to coma, and in severe cases, seizures. Kernig's sign (pain with knee extension while the hip is flexed) and Brudzinski's sign (neck flexion causing involuntary knee and hip flexion) are classic but insensitive physical exam findings.

Encephalitis, particularly herpes simplex virus (HSV) encephalitis, often presents with more pronounced cerebral dysfunction. While fever and headache are common, the hallmarks are behavioral changes, personality alterations, speech disturbances (aphasia), and focal neurological deficits like weakness or seizures. Temporal lobe involvement is classic for HSV, which can manifest with olfactory or gustatory hallucinations.

The moment either condition is suspected, the clock starts. The diagnostic and therapeutic pathway must be initiated simultaneously. A non-contrast head CT is often obtained prior to lumbar puncture (LP) to rule out mass effect that could precipitate brain herniation during the procedure. Crucially, if there is any delay in obtaining imaging or performing the LP, empiric antimicrobial therapy must be administered immediately, ideally after blood cultures are drawn.

The Diagnostic Cornerstone: Cerebrospinal Fluid Analysis

The lumbar puncture and subsequent CSF analysis are definitive for diagnosing meningitis and often crucial in evaluating encephalitis. The table below summarizes typical CSF profiles, but remember, these are patterns—atypical presentations occur.

For encephalitis, the CSF may show a lymphocytic pleocytosis with normal glucose and elevated protein. The critical test for HSV encephalitis is CSF polymerase chain reaction (PCR) for HSV DNA, which has high sensitivity and specificity.

Gram stain and culture of the CSF are sent to identify the specific bacterial pathogen, but results take 24-72 hours. CSF PCR panels can rapidly detect viral DNA/RNA (e.g., enteroviruses, HSV, VZV). In all cases, serum studies including blood cultures, inflammatory markers, and basic metabolic panels are obtained concurrently.

Empiric Antimicrobial Therapy: Protocols and Priorities

Treatment begins empirically, tailored to the most likely pathogens based on patient age, immune status, and epidemiology, then narrowed when culture and sensitivity results return.

For suspected bacterial meningitis in an immunocompetent adult:

• Empiric therapy must cover Streptococcus pneumoniae and Neisseria meningitidis. The standard regimen is a third-generation cephalosporin (e.g., ceftriaxone or cefotaxime) plus vancomycin (to cover penicillin- and cephalosporin-resistant S. pneumoniae).
• Dexamethasone, a corticosteroid, is recommended to be administered with or just before the first antibiotic dose in adults with suspected pneumococcal meningitis. It reduces neurological sequelae by mitigating the inflammatory response.

For suspected herpes simplex encephalitis:

• Intravenous acyclovir must be initiated whenever HSV encephalitis is suspected. Delaying acyclovir dramatically increases mortality and morbidity. The standard dose is high (10 mg/kg IV every 8 hours for adults) and treatment typically continues for 14-21 days, pending confirmation by CSF PCR. Do not wait for PCR results to start therapy.

Clinical Vignette: A 65-year-old man presents to the ED with 12 hours of progressive headache, fever to 102°F, and confusion. On exam, he is lethargic and has obvious nuchal rigidity. After drawing blood cultures, you order a STAT head CT and immediately administer ceftriaxone 2g IV, vancomycin 15-20 mg/kg IV, and dexamethasone 10mg IV. The CT shows no mass effect, so you perform an LP which reveals cloudy CSF with 2000 WBCs (90% neutrophils), protein 300 mg/dL, and glucose 20 mg/dL (serum glucose 100). Your empiric coverage was correct.

Complications, Prognosis, and the Path Forward

Even with optimal treatment, CNS infections carry significant risks. Complications of bacterial meningitis include hearing loss, seizures, cognitive deficits, hydrocephalus, and cerebral infarction. Encephalitis can leave patients with permanent memory impairment, personality changes, epilepsy, or focal neurological deficits.

The prognosis hinges almost entirely on the speed of diagnosis and initiation of appropriate therapy. Bacterial meningitis mortality remains around 15-25%, and neurological sequelae occur in up to 30% of survivors. HSV encephalitis mortality approaches 70% if untreated; with timely acyclovir, it falls below 20%, but over half of survivors have moderate or severe disability.

Management extends beyond antibiotics. It involves neurocritical care monitoring, seizure prophylaxis or management, controlling intracranial pressure, and comprehensive rehabilitation. Public health measures, such as identifying contacts of patients with N. meningitidis for antibiotic prophylaxis, are also a crucial component of care.

Common Pitfalls and How to Avoid Them

1. Delaying Empiric Therapy for Diagnostic Perfection: Waiting for CT or LP results before giving antibiotics or acyclovir is the most dangerous error.

• Correction: Draw blood cultures, then administer the first doses of empiric antimicrobials immediately upon clinical suspicion, even in the ambulance or before imaging.

1. Misinterpreting Atypical CSF Profiles: Not all bacterial meningitis presents with classic neutrophilic pleocytosis. Partially treated cases, infections with Listeria (which can cause a monocytic pattern), or in immunocompromised patients, the CSF can be deceptive.

• Correction: When clinical suspicion is high, treat empirically for bacterial meningitis even if the CSF profile is ambiguous. A low CSF glucose is a particularly strong indicator of bacterial infection.

1. Prematurely Stopping Acyclovir with a Negative Early PCR: HSV PCR sensitivity can be lower if CSF is obtained very early (<72 hours) after symptom onset in encephalitis.

• Correction: If clinical suspicion for HSV encephalitis remains high, continue acyclovir and repeat the LP for PCR in 24-72 hours. Do not discontinue therapy based on a single negative early test.

1. Overlooking Alternative or Coexisting Diagnoses: A patient with meningitis might also have a brain abscess or subdural empyema. Encephalitis can be autoimmune (e.g., anti-NMDA receptor encephalitis) rather than infectious.

• Correction: Maintain a broad differential. If a patient is not improving on appropriate antimicrobials, repeat imaging and consider autoimmune panels, paraneoplastic workups, or biopsy.

Summary

• Meningitis and encephalitis are neurological emergencies where hours matter. The cornerstone of management is the immediate initiation of empiric antimicrobial therapy upon suspicion, even before definitive diagnostic procedures.
• Lumbar puncture with CSF analysis is the diagnostic gold standard. Key differentiators are: bacterial (high neutrophils, high protein, low glucose) vs. viral (lymphocytes, moderate protein, normal glucose).
• Empiric bacterial meningitis treatment in adults typically involves ceftriaxone + vancomycin + dexamethasone. For any suspected herpes simplex encephalitis, high-dose IV acyclovir must be started immediately and should not be delayed for test results.
• Complications like hearing loss, seizures, and cognitive deficits are common, underscoring the importance of rapid treatment. Always consider public health implications for certain pathogens like Neisseria meningitidis.
• Avoid fatal pitfalls: never delay antibiotics for tests, interpret CSF in clinical context, and do not stop acyclovir based on a single early negative PCR if suspicion remains high.